Dolby Laboratories Inc (NYSE:DLB) Sentiment Change Report

July 17, 2017 - By test

 Dolby Laboratories Inc (NYSE:DLB) Sentiment Change Report

Sentiment for Dolby Laboratories Inc (NYSE:DLB)

Dolby Laboratories Inc (NYSE:DLB) institutional sentiment increased to 1.46 in Q4 2016. Its up 0.33, from 1.13 in 2016Q3. The ratio increased, as 140 institutional investors started new or increased holdings, while 96 reduced and sold their equity positions in Dolby Laboratories Inc. The institutional investors in our partner’s database reported: 50.18 million shares, down from 51.52 million shares in 2016Q3. Also, the number of institutional investors holding Dolby Laboratories Inc in their top 10 holdings was flat from 4 to 4 for the same number . Sold All: 28 Reduced: 68 Increased: 86 New Position: 54.

Dolby Laboratories, Inc. designs and makes audio and imaging products for the cinema, television, broadcast and entertainment industries. The company has market cap of $5.52 billion. The Company’s products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It has a 29.17 P/E ratio. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

About 488,190 shares traded or 70.78% up from the average. Dolby Laboratories, Inc. (NYSE:DLB) has risen 14.35% since July 17, 2016 and is uptrending. It has underperformed by 2.35% the S&P500.

Analysts expect Dolby Laboratories, Inc. (NYSE:DLB) to report $0.65 EPS on July, 26.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.65 EPS. DLB’s profit would be $66.34M giving it 20.77 P/E if the $0.65 EPS is correct. After having $0.47 EPS previously, Dolby Laboratories, Inc.’s analysts see 38.30 % EPS growth.

Crestwood Capital Management L.P. holds 5.32% of its portfolio in Dolby Laboratories, Inc. for 310,300 shares. Price Michael F owns 928,255 shares or 5.09% of their US portfolio. Moreover, Nantahala Capital Management Llc has 4.35% invested in the company for 927,907 shares. The Louisiana-based Diversified Investment Strategies Llc has invested 3.15% in the stock. Timucuan Asset Management Inc Fl, a Florida-based fund reported 704,240 shares.#img1#

Since January 1, 0001, it had 0 insider buys, and 13 sales for $5.12 million activity.

Dolby Laboratories, Inc. (NYSE:DLB) Ratings Coverage

Ratings analysis reveals 25% of Dolby Laboratories’s analysts are positive. Out of 4 Wall Street analysts rating Dolby Laboratories, 1 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $38 while the high is $54. The stock’s average target of $46.25 is -14.35% below today’s ($54) share price. DLB was included in 5 notes of analysts from October 22, 2015. As per Thursday, January 28, the company rating was upgraded by Dougherty & Company. Piper Jaffray maintained it with “Hold” rating and $4800 target in Friday, July 14 report. The stock has “Buy” rating by Dougherty & Company on Thursday, April 28. B. Riley & Co maintained the shares of DLB in report on Thursday, October 22 with “Neutral” rating. JP Morgan downgraded the shares of DLB in report on Friday, April 8 to “Neutral” rating.

More notable recent Dolby Laboratories, Inc. (NYSE:DLB) news were published by: which released: “Dolby Laboratories (DLB) Q2 2017 Results – Earnings Call Transcript” on April 27, 2017, also with their article: “Dolby, Netflix Tie Up to Deliver Better Streaming Experience” published on June 29, 2017, published: “Dolby Atmos for Music Debuts in the US” on July 10, 2017. More interesting news about Dolby Laboratories, Inc. (NYSE:DLB) were released by: and their article: “Dolby: An Overlooked Growth Story With Catalysts” published on January 05, 2017 as well as‘s news article titled: “Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2017 …” with publication date: July 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: